GTC

Ghost Tree Capital Portfolio holdings

AUM $276M
This Quarter Return
-2.74%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$202M
AUM Growth
+$202M
Cap. Flow
-$25.9M
Cap. Flow %
-12.83%
Top 10 Hldgs %
53.17%
Holding
52
New
5
Increased
8
Reduced
20
Closed
9

Top Buys

1
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
$7.61M
2
BCRX icon
BioCryst Pharmaceuticals
BCRX
$5.69M
3
FOLD icon
Amicus Therapeutics
FOLD
$5.68M
4
BCYC
Bicycle Therapeutics
BCYC
$4.39M
5
AXSM icon
Axsome Therapeutics
AXSM
$3.91M

Top Sells

1
ASND icon
Ascendis Pharma
ASND
$5.87M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
$5.09M
3
CMPS
Compass Pathways
CMPS
$4.64M
4
SRPT icon
Sarepta Therapeutics
SRPT
$3.91M
5
APLS icon
Apellis Pharmaceuticals
APLS
$3.81M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
RLMD icon
26
Relmada Therapeutics
RLMD
$48.8M
$2.7M 0.59%
100,000
-100,000
-50% -$2.7M
WHWK
27
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.3M
$2.55M 0.55%
150,000
-50,000
-25% -$849K
ACRS icon
28
Aclaris Therapeutics
ACRS
$223M
$2.16M 0.47%
125,000
-200,000
-62% -$3.45M
TARS icon
29
Tarsus Pharmaceuticals
TARS
$2.44B
$2.02M 0.44%
120,000
-50,000
-29% -$841K
NMTR
30
DELISTED
9 Meters Biopharma, Inc. Common Stock
NMTR
$1.95M 0.42%
162,500
– –
CRNX icon
31
Crinetics Pharmaceuticals
CRNX
$3.26B
$1.87M 0.4%
85,000
-33,344
-28% -$732K
STSA
32
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$1.8M 0.39%
473,562
-430,663
-48% -$1.64M
LPTX icon
33
Leap Therapeutics
LPTX
$12M
$1.74M 0.38%
99,371
-35,629
-26% -$624K
MRTX
34
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1.64M 0.36%
20,000
-10,000
-33% -$822K
VTGN icon
35
VistaGen Therapeutics
VTGN
$113M
$1.63M 0.35%
43,838
-22,829
-34% -$849K
SYRE icon
36
Spyre Therapeutics
SYRE
$1.02B
$1.58M 0.34%
+27,464
New +$1.58M
PRDS
37
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$614K 0.13%
85,000
+35,000
+70% +$253K
LRMR icon
38
Larimar Therapeutics
LRMR
$337M
$405K 0.09%
100,000
-125,000
-56% -$506K
PYXS icon
39
Pyxis Oncology
PYXS
$91.2M
$303K 0.07%
75,000
-220,000
-75% -$889K
ALDX icon
40
Aldeyra Therapeutics
ALDX
$350M
– –
0
– –
ALNY icon
41
Alnylam Pharmaceuticals
ALNY
$58.6B
– –
-30,000
Closed -$5.09M
CABA icon
42
Cabaletta Bio
CABA
$144M
– –
-135,000
Closed -$512K
CMPS
43
Compass Pathways
CMPS
$452M
– –
-210,000
Closed -$4.64M
GHRS icon
44
GH Research
GHRS
$870M
– –
-100,000
Closed -$2.33M
IMUX icon
45
Immunic
IMUX
$79.4M
– –
-165,000
Closed -$1.58M
IOVA icon
46
Iovance Biotherapeutics
IOVA
$800M
– –
0
– –
KURA icon
47
Kura Oncology
KURA
$732M
– –
-225,000
Closed -$3.15M
SPY icon
48
SPDR S&P 500 ETF Trust
SPY
$656B
– –
0
– –
XBI icon
49
SPDR S&P Biotech ETF
XBI
$5.29B
– –
0
– –
RETA
50
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-55,000
Closed -$1.45M
1
2
3